Skip to content

M-ARS ACL Post-marketing Surveillance Study

Clinical and Radiological Outcomes of M-ARS ACL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04462458
Enrollment
200
Registered
2020-07-08
Start date
2022-07-01
Completion date
2027-01-31
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament (ACL) Reconstruction

Brief summary

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.

Detailed description

This s a prospective, multicenter, non-controlled, observational study to evaluate the outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior cruciate ligament (ACL). Participants will be informed about the study, both orally and in writing, during a preoperative visit. The investigator will answer any questions that may arise and will collect the informed consent. During the study, enrolled participants will be able to withdraw at any time and for any reason. The study is conducted according to the following schedule: * V1 : Inclusion during a preoperative visit * V2: Surgery * V3: Follow-up visit at 1 month ± 15 days post-surgery * V4: Follow-up visit at 6 months ± 30 days post-surgery * V5: Follow-up visit at 12 months ± 60 days post-surgery * V6: Follow-up visit at 24 months ± 90 days post-surgery The following data will be collected: * Survival rate of implants evaluating the incidence of implants failure, where implant failure is defined as revision, loosening, or any definite change in the position of components (V3-V6). * Clinical and functional outcomes, measured with the International Knee Documentation Committee (IKDC) score (V1, V3-V6) * Quality of Life, measured with the EQ-5D score (V1, V3-V6) * Occurrence of intraoperative and postoperative complications (V2-V6) Depending on standard practice, imaging assessment of implants and bone tunnels may be performed. A web-based data collection tool will be used as Electronic Data Capture (EDC). All the information required by the protocol will be collected in electronic case report forms (eCRF). The statistical analysis will be performed according to a pre-established statistical analysis plan. Missing values will not be replaced by estimated values but will be considered as missing in the statistical analysis.

Interventions

DEVICEMedacta Anatomic Ribbon Surgery (M-ARS ACL)

M-ARS ACL allows to reconstruct the anterior cruciate ligament using the Anatomic Ribbon Technique

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years * Patients with ACL rupture requiring ACL reconstruction

Exclusion criteria

* Patients with malignant diseases (at the time of surgery) * Patients with proven or suspected infections (at the time of surgery) * Patients with functional deficits of the affected extremity (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)

Design outcomes

Primary

MeasureTime frameDescription
Survival rate6 monthsKaplan Meier method

Secondary

MeasureTime frameDescription
Survival rate1, 12, 24 monthsKaplan Meier method
Functional outcome1, 6, 12, 24 monthsInternational Knee Documentation Committee (IKDC) score
Quality of Life outcome1, 6, 12, 24 monthsEQ-5D score
Radiological outcome (optional)1, 6, 12, 24 monthsEvaluation of ligament osteointegration, femoral/tibial tunnel widening, presence of fluid in the femoral/tibial tunnel
Complication rateintraoperative, 1, 6, 12, 24 monthsOccurrence of intraoperative and postoperative complications

Countries

Austria, Germany

Contacts

Primary ContactDenise Falcone
falcone@medacta.ch+41916966060

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026